Miris Holding
38.70 SEK
Less than 1K followers
MIR
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Miris Holding
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.6 | 5.0 | 17.6 | 4.6 | 5.0 | 4.9 | 3.0 | 17.5 |
| EBITDA | -0.7 | -0.2 | -4.8 | -1.7 | -0.7 | -0.4 | -1.3 | -4.0 |
| EBIT | -0.7 | -0.2 | -5.3 | -1.7 | -0.7 | -0.4 | -1.3 | -4.0 |
| EBIT-% | -14.6 % | -4.8 % | -30.1 % | -36.2 % | -13.7 % | -7.3 % | -43.1 % | -22.8 % |
| Profit before taxes | -0.9 | -0.5 | -6.3 | -1.9 | -1.0 | -0.6 | -1.4 | -4.8 |
| Net income | -0.9 | -0.5 | -6.3 | -1.9 | -1.0 | -0.6 | -1.4 | -4.8 |